Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
10/2009
10/15/2009WO2009125483A1 Hard capsule
10/15/2009WO2009125465A1 Process for producing medicinal preparation for oral administration and apparatus for producing medicinal preparation for oral administration
10/15/2009WO2009125464A1 Medicinal preparation for oral administration
10/15/2009WO2009125432A2 Gas empowered expandable drug delivery systems
10/15/2009WO2009125332A1 New and safe procedure for immunization against infectious diseases agents
10/15/2009WO2009125246A1 Stable ophthalmic formulations
10/15/2009WO2009125226A1 Pharmaceutical depot comprising n-{5- t (cyclopropylamino) carbonyl] -2-methylphenyl}-3-flu0r0-4- (pyridin-2-ylmethox y) benzamide
10/15/2009WO2009125117A2 Dermatological composition that can be used in particular for the care and prevention of eschars
10/15/2009WO2009125087A1 Divisible galenic form allowing modified release of the active ingredient
10/15/2009WO2009125029A1 Method for preparing amorphous combinations of angiotensin ii receptor antagonists and diuretics
10/15/2009WO2009124984A1 Tablet comprising eprosartan mesylate
10/15/2009WO2009124983A1 Single dosage pharmaceutical formulation comprising eprosartan mesylate
10/15/2009WO2009124982A1 Granulation of active pharmaceutical ingredients
10/15/2009WO2009124834A1 Thermoplastic starch compounds
10/15/2009WO2009124586A1 Aqueous pharmaceutical formulation
10/15/2009WO2009124357A1 Fast dissolving oral formulations for critical drugs
10/15/2009WO2009105294A3 Topical compositions and methods for whitening skin
10/15/2009WO2009105278A3 Nanoparticle targeted drug delivery to the lungs using extra-testicular sertoli cells
10/15/2009WO2009102944A3 Transdermal micro-patch
10/15/2009WO2009096908A3 Extended-release fluvastatin tablet
10/15/2009WO2009086112A3 Apparatus and methods for delivering therapeutic agents
10/15/2009WO2009083686A9 Pharmaceutical compositions containing at least one proteinaceous active ingredient protected against digestive enzymes
10/15/2009WO2009073541A3 Thermoresponsive arginine-based hydrogels as biologic carriers
10/15/2009WO2009062193A3 Methods for administering corticosteroid formulations
10/15/2009WO2009060473A3 Injectable compositions, processes and uses thereof
10/15/2009WO2009053718A3 Immuno-modulatory composition
10/15/2009WO2009052888A3 Pharmaceutical product comprising yeast
10/15/2009WO2009047794A3 Docetaxel injectable composition, being absolutely free of ethanol
10/15/2009WO2009043926A3 Oral fast disintegrating tablets
10/15/2009WO2009013630A9 Hyperthermia devices and their uses with nanoparticles
10/15/2009WO2008129501A3 Pharmaceutical compositions of duloxetine
10/15/2009WO2008129465A9 Stable pharmaceutical compositions of bupropion
10/15/2009WO2008104960A8 Personal care product comprising cyclodextrin as fragrance- complexing material
10/15/2009WO2008102247A3 A polyamide rate-modulated monolithic drug delivery system
10/15/2009US20090259228 Methods for Preventing Posterior Capsular Opacification
10/15/2009US20090259160 System and composition for dendritic cell therapy using pharmacologically active microcarriers
10/15/2009US20090258952 Patch containing anti-inflammatory agent
10/15/2009US20090258948 Pharmaceutical salts
10/15/2009US20090258933 Oligonucleotides-transferring preparations
10/15/2009US20090258088 Use of materials and external stimuli for synovectomy
10/15/2009US20090258079 Biocompatible Block Copolymer, Use Thereof and Manufacturing Method Thereof
10/15/2009US20090258078 Antioxidant polymer nanocarriers for use in preventing oxidative injury
10/15/2009US20090258077 Composition and method for treating or preventing white spot syndrome virus
10/15/2009US20090258076 Water-soluble magnetic or metal oxide nanoparticles coated with ligands, preparation method and usage thereof
10/15/2009US20090258075 Respiratory Drug Condensation Aerosols and Methods of Making and Using Them
10/15/2009US20090258074 Mixtures of tannins, their production and use in medicaments or as disinfectants
10/15/2009US20090258073 Magnetic carrier and medical preparation for controllable delivery and release of active substances, methods of their production and methods of treatment using thereof
10/15/2009US20090258072 Large ultraviolet attenuating pigments
10/15/2009US20090258071 Compositions and methods for ph targeted drug delivery
10/15/2009US20090258070 Topical LFA-1 antagonists for use in localized treatment of immune related disorders
10/15/2009US20090258069 Delivery of LFA-1 antagonists to the gastrointestinal system
10/15/2009US20090258068 Titanium Oxide-Zinc Oxide Aggregate Powder And Production Method Thereof
10/15/2009US20090258067 Modified release composition of at least one form of venlafaxine
10/15/2009US20090258066 Compositions comprising weakly basic drugs and controlled-release dosage forms
10/15/2009US20090258065 Dermatological compositions comprising avermectin nanocapsules
10/15/2009US20090258064 Compositions of ucp inhibitors, fas antibody, a fatty acid metabolism inhibitor and/or a glucose metabolism inhibitor
10/15/2009US20090258063 Transdermal patch
10/15/2009US20090258062 Transdermal Therapeutic System Comprising Active Ingredient Particles and Having Increased Active Ingredient Flux
10/15/2009US20090258061 Once-a-day replacement transdermal administration of fentanyl
10/15/2009US20090258060 Hydrogel Compositions
10/15/2009US20090258059 Stabilized foam for medical PSA substrate
10/15/2009US20090258058 Novel silicone film former for delivery of actives
10/15/2009US20090258057 Synthetically Functionalized Living Cells
10/15/2009US20090258056 Systems and methods for preparing autologous fibrin glue
10/15/2009US20090258052 Compounds and methods for altering bone growth
10/15/2009US20090258051 Microbes Encapsulated Within Crosslinkable Polymers
10/15/2009US20090258049 Drug eluting expandable devices
10/15/2009US20090258046 Composition, formulations and kit for treatment of respiratory and lung disease with non-glucocorticoid steroids and/or ubiquinone and a bronchodilating agent
10/15/2009US20090258040 Steroid treatment for hot flashes
10/15/2009US20090258039 Method of administering a pharmaceutical active ingredient
10/15/2009US20090258038 Water-soluble compositions of bioactive lipophilic compounds
10/15/2009US20090258033 HCV E1E2 vaccine compositions
10/15/2009US20090257980 Anti-virus therapy for respiratory diseases
10/15/2009US20090257959 Pesticidal compositions
10/15/2009US20090257957 Aerosolized LFA-1 antagonists for use in localized treatment of immune related disorders
10/15/2009US20090257950 with target membrane or other hydrophobic proteins (G protein coupled receptor protein) or membrane fragments to form soluble nanoscale particles which preserve their native structure and function; allows manipulation of incorporated proteins in solution or on solid supports
10/15/2009US20090256006 Generation of therapeutic microfoam
10/15/2009DE19907878B4 Verfahren zum Herstellen von Mitteln zur Nahrungsergänzung A process for preparing compositions as a food supplement
10/15/2009DE102008011800A1 Orally disintegrating film, useful e.g. to combat parasites in animals, preferably fish, exotic or wild animals, comprises a matrix made of a polymer of modified pea starch and an antiparasitic agent e.g. ivermectin and selamectin
10/15/2009DE102005035986B4 Steriles tropfbares mehrphasiges emulgatorfreies ophthalmisches Präparat Sterile, droppable multiphase emulsifier-free ophthalmic preparation
10/15/2009CA2725822A1 Pharmaceutical depot comprising n-{5-[(cyclopropylamino)carbonyl]-2-methylphenyl}-3-fluoro-4-(pyridin-2-ylmethoxy)benzamide
10/15/2009CA2721153A1 Compositions of hydrophobic taxane derivatives and uses thereof
10/15/2009CA2721115A1 Tablet comprising eprosartan mesylate
10/15/2009CA2721112A1 Thermoplastic starch compounds
10/15/2009CA2721072A1 Anticancer methods employing extracts of gleditsia sinensis lam
10/15/2009CA2721071A1 Methods and use of inducing apoptosis in cancer cells
10/15/2009CA2721067A1 Dried formulations
10/15/2009CA2721014A1 Aqueous pharmaceutical formulation
10/15/2009CA2720756A1 Stabilized oleosome preparations and methods of making them
10/15/2009CA2720755A1 Controlled release of active agents from oleosomes
10/15/2009CA2720744A1 Granulation of active pharmaceutical ingredients
10/15/2009CA2720592A1 Single dosage pharmaceutical formulation comprising eprosartan mesylate
10/15/2009CA2719364A1 Butenafine hydrochloride-containing aqueous patch
10/14/2009EP2108677A1 Thermoplastic starch-containing materials
10/14/2009EP2108365A1 Single dosage pharmaceutical formulation comprising eprosartan mesylate
10/14/2009EP2108364A1 Water-free agent carrier matrix for hydrophilic agents
10/14/2009EP2108363A1 Sustained-release composition comprising lactic acid-glycolic acid copolymer and process for producing the same
10/14/2009EP2108362A2 Method of producing a cationic liposomal preparation comprising a lipophilic compound
10/14/2009EP2108361A1 Emulgating microparticles made of lipids for stabilising lipophilic agents for cosmetic use
10/14/2009EP2108360A2 Topical Pharmaceutical Foam Composition
1 ... 998 999 1000 1001 1002 1003 1004 1005 1006 1007 1008 1009 1010 1011 1012 1013 1014 1015 1016 1017 1018 ... 2991